Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Vijay Patil

ResearcherPublications, citations & collaboration network

Vijay Patil is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 379 works, 4,409 citations, an h-index of 31 and an i10-index of 89.

379
Works
4,409
Citations
31
h-index
89
i10-index

How has Vijay Patil's publication output changed over time?

ScholarIQpublication output · 2014–2023

Output grew0% over the shown period — from 1 works in 2014 to 1 in 2023.

1
1
1
2
2
1
1
1
1
201420152016201720192020202120222023

What are the most-cited papers on Vijay Patil?

ScholarIQmost cited works
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer
Vanita Noronha, Vijay Patil, Amit Joshi, Nandini Menon, Anuradha Chougule, Abhishek Mahajan, Amit Janu, Nilendu Purandare, Rajiv Kumar, Sucheta More, Supriya Goud, Nandkumar Kadam, Nilesh Daware, Atanu Bhattacharjee, Srushti Shah, Akanksha Yadav, Vaishakhi Trivedi, Vichitra Behel, Amit Dutt, Shripad Banavali, Kumar Prabhash
Journal of Clinical Oncology. 2019424 Citations
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Vanita Noronha, Amit Joshi, Vijay Patil, Jaiprakash Agarwal, Sarbani Ghosh Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Anil D′Cruz, Shripad Banavali, Prathamesh Pai, Pankaj Chaturvedi, Devendra Chaukar, Nikhil Pande, Arun Chandrasekharan, Vikas Talreja, Dilip Harindran Vallathol, Vijayalakshmi Mathrudev, Aparna Manjrekar, Kamesh Maske, Arati Sanjay Bhelekar, Kavita Nawale, Sadhana Kannan, Vikram Gota, Atanu Bhattacharjee, Shubhada Kane, Shashikant Juvekar, Kumar Prabhash
Journal of Clinical Oncology. 2017340 Citations
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study
Vijay Patil, Vanita Noronha, Nandini Menon, Rahul Rai, Atanu Bhattacharjee, Ajay Singh, Kavita Nawale, Shweta Jogdhankar, Rupali Tambe, Sachin Dhumal, Riddhi Sawant, Mitali Alone, Devanshi Karla, Zoya Peelay, Shruti Pathak, Arun Balaji, Suman Kumar, Nilendu Purandare, Archi Agarwal, Ameya Puranik, Abhishek Mahajan, Amit Janu, Gunjesh Kumar Singh, Neha Mittal, Subhash Yadav, Shripad Banavali, Kumar Prabhash
Journal of Clinical Oncology. 2022211 Citations
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
Vijay Patil, Kumar Prabhash, Vanita Noronha, Amit Joshi, Vamshi Muddu, Sachin Dhumal, S. Arya, S Juvekar, P. Chaturvedi, Devendra Chaukar, Prathamesh Pai, Shubhada Kane, Aswari Patil, J.P. Agarwal, S. Ghosh-Lashkar, Anil D′Cruz
S102916872. 2014175 Citations
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Vijay Patil, Vanita Noronha, Amit Joshi, Jaiprakash Agarwal, Sarbani Ghosh Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Manoj B. Mahimkar, Shashikant Juvekar, Supreeta Arya, Abhishek Mahajan, Archi Agarwal, Nilendu Purandare, Venkatesh Rangarajan, Arun Balaji, Sameer Chaudhari, Shripad Banavali, Sadhana Kannan, Atanu Bhattacharjee, Anil D′Cruz, Pankaj Chaturvedi, Prathamesh Pai, Devendra Chaukar, Gouri Pantvaidya, Deepa Nair, Sudhir Nair, Anuja Deshmukh, Shivakumar Thiagarajan, Vijayalakshmi Mathrudev, Aparna Manjrekar, Sachin Dhumal, Kamesh Maske, Arti Bhelekar, Kavita Nawale, Arun Chandrasekharan, Nikhil Pande, Alok Goel, Vikas Talreja, Vijai Simha, Sujay Srinivas, Rohit Swami, Dilip Harindran Vallathol, Hollis Dsouza, Sameer Shrirangwar, Siddharth Turkar, George Abraham, Aditi Harsh Thanky, Usha Patel, Manish Pandey, Kumar Prabhash
Cancer. 2019133 Citations

Related on ScholarIQ

Homi Bhabha National Institute
Institution
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer
Paper
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
Paper
Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study
Paper
Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers
Paper
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Paper
470M+ articles · free account